Maintenance Immune Check-point Inhibitor Following Post-operative Chemo-radiation in Subjects With HPV-negative HNSCC

Condition:   Squamous Cell Head and Neck Carcinoma
Interventions:   Drug: Durvalumab;   Radiation: radiotherapy;   Drug: Placebo;   Drug: Cisplatin
Sponsor:   European Organisation for Research and Treatment of Cancer - EORTC
Not yet recruiting

https://ift.tt/2MIt5MZ